This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
By understanding what led retail pharmacy team members to take these drastic actions, we can look at what independentpharmacies can do to avoid similar issues and also how independents can help members of these communities affected by the closures of retail chains.
MCCPDC is able to offer low pricing because they “cut out the pharmacy middlemen and negotiate directly with manufacturers” In this blog, we will explore the differences between independentpharmacies and Mark Cuban Cost Plus Drug Company and how MCCPDC could potentially affect independentpharmacies. .
With reimbursements dwindling and the so-called “ DIR Apocalypse ” or “DIR Armageddon” on the horizon, no explanation is needed as to why independentpharmacies are seeking innovative ways to expand their revenue streams beyond traditional prescription dispensing.
The NCPA Digest reports that the GDR for independentpharmacies was only 86% for 2020.” ” Including compounds with brands will understate the GDR, with generics will overstate the GDR, and excluding compounds will deflate the volume of the pharmacy, increasing the calculated cost of dispensing.
Key Medicare tools to safeguard against pharmacy fraud and inappropriate billing do not apply to Part D. NHC comments to the FTC on PBM business practices and the impact on independentpharmacies and consumers. Prior authorization and association with delayed or discontinued prescriptionfills. Blendon, R.,
Small molecule drugs make up over 90% of prescriptionsfilled in the U.S. Additionally, PBM-affiliated pharmacies were reimbursed at significantly higher rates than independentpharmacies, further disadvantaging unaffiliated competitors.The report also noted that plan sponsors paid $4.8 Read the FTC Report here.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content